Introduction
The Fusarium fungi represent the most frequent toxinproducing species affecting a multitude of field crops in regions with a moderate climate (Bennett and Klich, 2003; Gutleb et al., 2003; Krska et al., 2001) . Fusarium mycotoxins that pose a threat to human health include fumonisins, zearalenone and a series of tricyclic sesquiterpenoids characterised by a 12,13-epoxy-trichothecene ring structure. Type A trichothecenes additionally contain an isovaleryl moiety at the C-8 position (Figure 1 ) which, in the case of type B trichothecenes, is replaced by a carbonyl substitution (Creppy, 2002; Josephs et al., 2004) . Deoxynivalenol (DON), a prototypical type B trichothecene, is the most abundant and widely studied representative of this group of mycotoxins. The less important type C and D trichothecenes contain a second epoxide structure at C-7,8 or C-9,10 and a macrocyclic ring between C-4 and C-15, respectively. Compared to DON, type A trichothecenes such as T-2 or its metabolite HT-2 occur less frequently and at lower mean concentrations (Schothorst and Van Egmond, 2004) . However, these two major type A trichothecenes exert a more potent irritant action on proliferating cells of the skin, gastrointestinal mucosa or other epithelial tissues (Creppy, 2002) . As a consequence, type A trichothecenes exhibit considerably higher toxicities than DON. For example, the oral LD 50 of T-2 ranges from 4 mg/kg body weight in rats or swine, to 7 mg/kg in mice. In comparison, the oral LD 50 of DON amounts to 46 mg/kg body weight in mice (Josephs et al., 2004) . The immune system is another major target of these toxins, leading to reduced leukocyte counts, depressed antibody responses and decreased resistance to pathogens (Li et al., 2006; Pestka et al., 2004) . Chronic exposure to type A trichothecenes has been associated with an elevated cancer risk, consistent with their mutagenic or clastogenic properties in some genotoxicity tests (Li, 1988; Schlatter, 2004) . Finally, T-2 is often discussed as a potential warfare agent (Bennett and Klich, 2003; Ler et al., 2006) . In view of these manifold hazards, various public health authorities have introduced legislation to set strict allowable levels of type A trichothecenes in food (Van Egmond et al., 2007) . A lowest observed effect of 29 µg/kg body weight (based on changes in white and red blood cell counts in pigs) was used by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) to perform an overall risk assessment of T-2 (Canady et al., 2001) . A safety factor of 500 was introduced to derive a maximal tolerable intake for T-2 of 60 ng/kg body weight. Because the adverse effects of T-2 and HT-2 could not be differentiated, they were both included in the temporary tolerable daily intake (t-TDI) adopted by the European Union, yielding a group t-TDI of 60 ng/kg body weight for T-2 and HT-2, alone or in combination. According to regulation EC 856/2005, maximum residue levels for the sum of T-2 and HT-2 in cereals or other relevant products are expected in the near future.
The presence of mycotoxins in agricultural commodities appears unavoidable. Various pre-harvest strategies, including the use of fungicides, have not been efficient in preventing the contamination of crop products with Fusarium toxins. Indeed, a comprehensive consumption study performed throughout Europe suggests that the dietary intake of T-2 and HT-2 in many countries may exceed the proposed t-TDI (Schothorst and Van Egmond, 2004) . Thus, to reduce human exposure to these hazardous contaminants, it is necessary to screen a wide range of raw and manufactured foods that are consumed on a daily basis. To date, reliable screening systems for type A trichothecenes are dependent on the availability of immunoassays using specific antibodies against T-2 and HT-2 (Molinelli et al., 2008; Park and Chu, 1996; Schneider et al., 2004) . Here, we propose an alternative screening strategy based on the ability of these compounds to re-programme the genome of routinely cultured human epithelial cells. In fact, we observed that parts per billion levels of both T-2 and HT-2 trigger substantial changes of transcription involving multiple genes in human MCF7 cells and we exploited this finding to develop new screening bioassays for the detection of type A trichothecenes in food samples.
Materials and methods

Chemicals and samples
Methanol (hyper grade) and acetonitrile (gradient grade) were purchased from Merck (Darmstadt, Germany). Dimethyl sulfoxide (DMSO, molecular biology grade) was from Sigma-Aldrich (Buchs, Switzerland). Ultrapure water produced by a Barnstead Nanopure Diamond system (Barnstead International, Dubuque, IA, USA) was used for all experiments. T-2, HT-2, DON and nivalenol (NIV) were purchased from Biopure (Tulln, Austria). Stocks of these mycotoxin standards were prepared in DMSO and stored at -20 °C. Blank cereal-based products were obtained from Nestlé (Lausanne, Switzerland). A validated liquid chromatography/tandem mass spectrometry procedure with a limit of detection of 0.8 ng/g (Sulyok et al., 2007) was used as the reference method to exclude trichothecene contamination of these matrices. The protein kinase inhibitors PD98059 and SB20358 were from Calbiochem (San Diego, CA, USA).
Extraction and cleanup of matrices
Samples (25 g) of finely ground baby food or breakfast cereals were extracted in a ratio of 1:4 (w/v) with acetonitrile/ water (84:16, v/v). After shaking for 2 h, the crude extracts were passed through filter paper (Machery Nagel, Dueren, Germany) and a portion of 8 ml was processed by solidphase extraction through MycoSep 227 Trich+ cartridges following the manufacturer's instructions (Romer Labs, Union, MO, USA). From these purified extracts, an aliquot of 4 ml was evaporated to dryness under nitrogen and stored at 4 °C.
Cell culture and protein synthesis assays
Human MCF7 breast cancer cells subtype BUS were kindly provided by A.M. Soto and C. Sonnenschein (Tufts University, Sackler School of Graduate Biomedical Sciences, Boston, MA, USA). All media and other cell culture ingredients were purchased from Invitrogen (Carlsbad, CA, USA). MCF7 cells were grown to a nearly confluent monolayer in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% (v/v) foetal bovine serum (FBS), penicillin G (0.1 U/ml) and streptomycin (0.1 µg/ml). Before each treatment, the cells were pre-incubated for 24 h in oestrogen-free medium consisting of phenol redfree DMEM, 5% (v/v) dextran-coated charcoal-stripped FBS (Soto et al., 1995) and the antibiotics penicillin G and (Legler et al., 1999) . Because the expression of this luciferase reporter gene construct was under tight control of a minimal promoter containing oestrogen response elements, the cells were subsequently incubated in medium supplemented with 30 pM 17β-estradiol. Thereafter, luciferase induction was determined by measuring its enzymatic activity in cell lysates using the Luciferase Assay System (Promega, Madison, WI, USA). Secretion of the CCL2 (chemokine ligand 2) polypeptide was determined by measuring the concentration of this cytokine in the medium using the Quantikine ELISA kit from R&D Systems (Minneapolis, MN, USA).
Treatment with standards or food extracts
For the transcriptomic assays, MCF7 cells were treated in 6-well plates with the indicated concentrations of T-2, HT-2, DON or NIV standards diluted in oestrogen-free medium.
The final DMSO solvent concentration in the assay medium was 0.1% (v/v). Alternatively, the residues obtained by extraction or cleanup of food samples (from 1 g of matrix) were directly dissolved in 2 ml of oestrogen-free medium containing 0.3% (v/v) DMSO and 1.7% (v/v) ethanol. After 24-h exposure periods, the cells were removed from their culture plates by trypsin treatment.
RNA extraction and complementary strand synthesis
First, the RNA was extracted using the RNeasy Mini kit (Quiagen) according to the manufacturer's protocol. Amount and purity of this total RNA fraction was evaluated by UV spectrophotometry (260 and 280 nm wavelength).
To perform high-density microarray hybridisations, the Gene-Chip expression and IVT labelling kits (Affymetrix, Santa Clara, CA, USA) were used for the synthesis of complementary DNA and biotinylated complementary RNA, respectively (Dip et al., 2008) . For the hybridisation to low-density microarrays, the cellular RNA (1 µg) was first converted to complementary DNA using the RevertAid H Minus M-MuLV reverse transcriptase (MBI Fermentas, Burlington, Canada), followed by a multiplex linear amplification reaction (40 cycles) in the presence of the Therminator DNA polymerase (New England Biolabs, Ipswich, MA, USA) and 1 mM biotin-16-dUTP (Schüler et al., 2006) . Complementary DNA for the real-time PCR reactions was synthesised from 2 µg of total RNA using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions.
High-density microarray hybridisations and data analysis
The biotin-labelled complementary RNA was fragmented and hybridised on human genome U133 plus 2.0 microarrays (Affymetrix, Santa Clara, CA, USA) following the manufacturer's guidelines. After hybridisation (16 h), the microarrays were washed on the Affymetrix Fluidics Station 400. Staining of the hybridised probes was carried out using fluorescent straptavidin-phycoerythrin conjugates (1 mg/ml; Invitrogen). The microarrays were scanned on an Affymetrix laser instrument. The resulting data were controlled for handling artifacts, normalised, analysed and filtered using the Expressionist software (Genedata AG, Basel, Switzerland). Finally, t-tests were performed by twosided ANOVA between solvent controls and trichothecenetreated samples to assess the statistical significance of each differential gene expression. False discovery rates were determined according to the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) .
Low-density microarray hybridisations
DNA microchips of 9 mm 2 , printed with 156 oligonucleotide probes, were provided by Clondiag (Jena, Germany). The biotin-labelled linear amplification products (0.16 ng/µl) were heat-denatured (95 °C, 5 min) and hybridised to the low-density microchips in the ArrayTube format. The arrays were conditioned at 30 °C by rinsing twice for 5 min with 500 µl hybridisation buffer (6×SSPE; 1×SSPE = 0.15 M NaCl, 10 mM sodium phosphate, pH 7.4, 1 mM EDTA). The hybridisations with 100 µl biotinylated DNA were performed for 1 h at 60 °C. Subsequently, the arrays were washed with 500 µl of 2×SSC containing 0.01% (v/v) Triton X-100 (for 5 min at 30 °C), with 2×SSC (5 min, 20 °C) and finally with 0.2×SSC (5 min, 30 °C) (1×SSC = 0.15 M NaCl, 15 mM trisodium citrate, pH 7.0). After blocking with 2% (w/v) milk powder (Bio-Rad, Hercules, CA, USA) in 500 µl of 6×SSPE containing 0.005% (w/v) Triton X-100 (15 min, 30 °C), the arrays were incubated for 15 min at 30 °C with 100 µl of a 1:25,000 dilution of horseradish peroxidase-streptavidin conjugates (1 mg/ml; Thermoscientific, Rockford, Canada) freshly prepared in 6×SSPE containing 0.005% (w/v) Triton X-100. Thereafter, the arrays were washed with 500 µl of 2×SSC containing 0.01% (w/v) Triton X-100 (2 min, 30 °C), with 2×SSC (5 min, 20 °C) and once with 0.2×SSC (5 min, 20 °C). The peroxidase precipitation reaction (100 µl TrueBlue peroxidase substrate; KPL, Gaithersburg, MD, USA) was monitored in the ATR01 reading device (Clondiag) by recording the image after 10 min of incubation at 25 °C. Data acquisition and analysis were carried out using the IconoClust version 2.2 software (Clondiag). (Livak and Schmittgen, 2001 ) using the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript as an endogenous control.
Quantitative PCR reactions
Results and discussion
Inhibition of protein synthesis
At the molecular level, trichothecenes interfere with the active site of peptidyl transferases in the 60S ribosomal subunit, thus blocking protein synthesis (Carter et al., 1976; Cundliffe and Davies, 1977; Smith et al., 1975) . The particular susceptibility of MCF7 cells to this ribosomeinhibiting effect was tested by monitoring the intracellular synthesis of a reporter enzyme. For that purpose, MCF7 cells were transfected with a vector construct driving the expression of firefly luciferase. Immediately after these transfections, the cells were incubated with trichothecenes for a period of 8 h. Finally, the level of luciferase activity in cell lysates was determined to assess the impact of each trichothecene on de novo protein synthesis. Figure 2A shows that T-2 and HT-2 inhibit the ribosomal activity in a dose-dependent manner with an approximate EC 50 value of 1.5 ng/ml. In a direct comparison between different trichothecenes, tested at a concentration of 50 ng/ml, the presence of T-2 or HT-2 resulted in nearly complete (approximately 85%) suppression of protein synthesis, whereas only partial inhibition was observed in cells exposed to DON or NIV ( Figure 2B ).
Global expression analysis
Both type A and B trichothecenes have been shown previously to induce transcriptional changes in animal studies. In rodents, DON is able to alter gene expression in the spleen, whereas type A trichothecenes induce such changes in the liver, placenta and foetal brain (Kinser et al., 2004; Sehata et al., 2004 Sehata et al., , 2005 . To test whether similar biological responses may be reproduced in a stable cell line, human MCF7 cells were exposed in triplicate experiments to type A trichothecenes (T-2 and HT-2) at a concentration of 200 ng/ml or type B trichothecenes (DON and NIV) at a concentration of 400 ng/ml. After 24-h incubations, the RNA transcripts were extracted, converted to biotinlabelled complementary RNA and hybridised to Affymetrix high-density microarrays engineered to detect as many as 47,000 different human transcripts.
The triplicate sets of high-density microarray data were normalised and subjected to principal component analysis (PCA), which is a multivariate reduction technique commonly applied to classify complex transcriptional patterns. PCA consists of a mathematical procedure that converts a large number of possibly correlated variables into few independent variables designated principal components (Van der Werf et al., 2006) . The output of this PCA analysis can be visualised in three-dimensional plots, where each point represents the entire transcriptome generated in a particular treatment ( Figure 3A ). Transcriptomes that cluster together are overall very similar, whereas transcriptional profiles that differ from each other are located further apart. Thus, the graphical representation of this PCA analysis in Figure 3A demonstrates that all trichothecenes provoked expression fingerprints that are different from those found in solvent controls. Also, the triplicate experimental data obtained with T-2 and HT-2 form a group clustering closely together, indicating that these type A trichothecenes induce similar transcriptomes that are clearly distinguishable from those elicited by DON and NIV.
Subsequently, the level of each individual transcript in the treated cells was compared with the respective solvent controls to identify differentially expressed genes. The average fold changes in each triplicate experiment were plotted as a function of the corresponding P values obtained by two-sided ANOVA ( Figure 3B ). This graphical representation, referred to as volcano plot, demonstrates in quantitative terms the strong effect of type A trichothecenes on the overall gene expression pattern with a large number of up-and down-regulated transcripts. Finally, the data were filtered using a threshold for statistical significance of P<10 -4 . Despite such a stringent cut-off, the statistical analysis revealed >2,000 human transcripts that were significantly regulated following the treatments with either T-2 or HT-2 (Table 1) .
Profiling on low-density microchips
Based on the gene expression changes determined at the global genomic level, several human transcripts were selected to be included as targets for the low-density microarrays dedicated to trichothecene screening. Clondiag microarrays of 9 mm 2 (microchips) were printed with 28-residue oligonucleotides whose sequence is complementary to the following trichothecene-regulated transcript: chemokine ligand 2 (CCL2), cystatin A, deathassociated protein kinase 3 (DAPK3), DNA damageinducible transcript 4, Down syndrome critical region gene 1 (DSCR1), eukaryotic initiation factor 2B (EIF2B), guanylate binding protein 2 (GBP2), high-mobility group box 2, insulin induced gene 1, interleukin 32 (IL32), isocitrate dehydrogenase 1, latexin, lymphotoxin beta (LTB), melanoma-associated antigen 1-like 1, pre-B-cell leukaemia homeobox-1 (PBX1), programmed cell death 4, ras-like without CAAX 1, sarcoglycan gamma (SGG), tissue factor pathway inhibitor, tumor necrosis factor alpha-induced protein 3 (TNFAIP3) and zinc finger protein 588. In addition, the microchips contain oligonucleotide sequences for the detection of glyceraldehyde-3-phosphate (GAPDH) and actin beta (ACTB) transcripts, which code for housekeeping factors that serve as endogenous controls. Each of these transcripts is represented by 2-5 different complementary sequences, with duplicate oligonucleotides being located at distinct sites of the array. One pair of these probes covers a sequence that is displayed on the previously used Affymetrix platform. Extra sequences were designed on the basis of melting point predictions to achieve maximal selectivity and hybridisation efficiency.
To determine expression fingerprints on low-density microchips, the RNA was isolated from MCF7 cells and the transcripts coding for the aforementioned factors were amplified by a linear PCR reaction in the presence of specific primers and a biotinylated deoxyribonucleotide analogue. These amplification reactions yield biotinlabelled complementary DNA that was directly used for the microchip hybridisations (Figure 4) . First, transcriptional fingerprints were determined with RNA extracted from MCF7 cells treated for 24 h with solvent ( Figure 4A ) or with a T-2 standard at the concentration of 20 ng/ml ( Figure 4B ). In this side-by-side comparison, housekeeping genes like GAPDH or ACTB exhibited similar levels of expression. Instead, several trichothecene-regulated genes displayed higher transcript levels in the toxin-treated cells ( Figure  4B ) than in the solvent control ( Figure 4A ).
This fingerprinting analysis was then applied to representative food samples (breakfast cereals spiked with T-2 or HT-2 at a concentration of 20 ng/g) that were processed by acetonitrile/water extraction followed by cleanup through a MycoSep cartridge ( Figure 4C ). The extracted residues were dissolved in cell culture medium (2 ml of medium for each 1 g of cereal sample), which was then used to expose MCF7 cells. After 24 h, the RNA was isolated and processed by linear amplification to determine gene expression changes on the microchips. The resulting hybridisation intensities were normalised against GAPDH endogenous controls and the final expression fingerprints were compared to those obtained with a blank cereal sample. Figure 4D describes the up-or down-regulation of individual transcripts following exposure to the samples fortified with either T-2 or HT-2. These results indicate that the Clondiag microchip provides a practical platform to screen for type A trichothecenes by expression fingerprinting. A similar array based on oestrogen-dependent genes (Dip et al., 2008) will be employed in the future for the detection of zearalenone.
Confirmation at transcript and protein levels
To substantiate the hybridisation findings with an exactly quantitative method, MCF7 cells were treated for 24 h with T-2 (50 ng/ml). Subsequently, a selection of mRNA transcripts was subjected to analysis by real-time reverse transcriptase-PCR (RT-PCR) using fluorescent TaqMan probes. The quantity of each mRNA was normalised to the level of the endogenous GAPDH reference sequence and, finally, the fold changes were calculated against the corresponding solvent controls. These RT-PCR determinations revealed a dose-dependent induction of the CCL2 transcript with an EC 50 of ~30 ng/ml (data not shown) and a maximal induction that reaches a value of >5,000-fold ( Figure 5A ). Among those genes that were down-regulated following the T-2 treatment, we found that the SGG transcript level was reduced >40-fold ( Figure  5A ). As a consequence, we further used these CCL2 and SGG transcripts as molecular markers of gene expression changes induced by type A trichothecenes.
To determine whether the observed transcriptomic effects translate to changes of expression at the protein level, we then tested the ability of MCF7 cells to secrete the CCL2 polypeptide. This particular cytokine was detected in the cell culture medium using a commercially available enzyme immunoassay. In agreement with the marked increase in transcript levels, we observed a strong induction of secreted chemokine protein when cells were exposed to 10 ng/ml T-2 ( Figure 5B ). However, this protein induction was clearly attenuated at higher toxin concentrations ( Figure 5B ), thus reflecting the progressively increased degree by which ribosomal protein synthesis is inhibited (see Figure 2A) . In light of this ribosomal effect, it is certainly more accurate to monitor CCL2 transcripts rather than the downstream polypeptide product.
Differential involvement of mitogen-activated protein kinases
Like other inhibitors of protein synthesis, trichothecenes trigger a ribotoxic stress response that leads to regulation of the transcriptional machinery through multiple signalling cascades (Iordanov et al., 1998; Zhou et al., 2003 Zhou et al., , 2005 . Mitogen-activated protein kinases (MAPKs) are critical for the intracellular transmission of signals from outside the cell to the nucleus or between distinct cellular compartments.
MAPK subfamilies include the extracellular signal-regulated kinases (ERKs) as well as the p38 protein kinase. In general, the ERKs are thought to mediate physiologic growth stimuli whereas p38 represents an important player in the cellular response to environmental stressors (Iordanov et al., 1998) . Previous studies established that gene induction following exposure to DON is primarily mediated by the p38 protein kinase. In fact, an inhibitor of p38 (SB20358) suppresses the induction of DON-responsive genes, whereas the ERK inhibitor PD98059 has been shown to potentiate this transcriptional response (Chung et al., 2003; Islam et al., 2006; Zhou et al., 2005) . In the present study, exactly the same inhibitors exerted a distinctly different effect on T-2 dependent transcriptional profiles. In fact, the ERK inhibitor PD98059 completely abrogated the CCL2 induction when MCF7 cells were challenged with 10 ng/ml T-2 ( Figure 5C ). In contrast, the p38 inhibitor resulted in a more moderate decrease of CCL2 induction ( Figure 5D ). 
RNA analysis
Taken together, these findings suggest that distinct ribotoxic stressors trigger diverging branches of MAPK pathways and that, in particular, the changes of gene expression induced by T-2 and DON (the major representatives of type A and type B trichothecenes, respectively) depend at least in part on different MAPK subfamilies.
Additivity and specificity of the transcriptomic-based bioassay
Most food commodities contaminated by T-2 also contain the hydroxylated HT-2 metabolite (Klötzel et al., 2006; Molinelli et al., 2008; Trebstein et al., 2008) . Thus, we used the CCL2 and SGG marker transcripts to determine how the bioassay results were influenced by the simultaneous exposure of MCF7 cells to both T2 and HT-2. These mixture experiments indicate that, particularly in the lower dose range, the two compounds interact in an additive manner to up-regulate the CCL2 transcript and, concomitantly, downregulate the SGG messenger. In fact, the joint transcriptional effects of T-2 and HT-2, mixed at a concentration of 5 ng/ ml each, are more severe than that of either individual component alone ( Figure 6A ). Additionally, we confirmed by PCR analysis the previous Affymetrix data indicating that the same transcripts are not regulated following an incubation with type B trichothecenes, which are normally found in contaminated food at higher levels than the type A counterparts. Briefly, MCF7 cells were treated for 24 h with DON and NIV at a concentration of up to 700 ng/ml, but these type B trichothecenes were unable to induce any Figure 6B shows that a distinct transcript (GBP2, guanylate-binding protein 2) is induced to similar levels by treatment with DON and T-2. The GBP2 transcript was selected as a reference because, in the previous global expression analysis, it was induced by all tested trichothecenes. Thus, these findings indicate that the CCL2 and SGG transcripts constitute specific markers for the presence of type A trichothecenes, whereas GBP2 is a more general marker of the overall trichothecene content.
Dual PCR format
The CCL2 and SGG sequences were exploited to develop a dual PCR-based bioassay. To that end, blank samples representing typical food matrices (baby food and breakfast cereals) were spiked with T-2 (10 and 50 ng/g) and extracted with acetonitrile/water followed by cleanup through MycoSep columns (see Figure 4C ). The final residues were reconstituted in 2 ml of cell culture medium for each 1 g of initial sample material (translating to an approximate toxin concentration of 5 and 25 ng/ml in the cell culture medium). A subsequent 24-h incubation of MCF7 cells with these different fractions resulted in the expected CCL2 induction and SGG repression (Figure 7 ). In contrast, the same transcripts remained unaffected when the experiment was performed with blank food samples devoid of type A trichothecenes. Thus, the analysis of both fortified food samples by monitoring transcriptomic changes yielded unequivocal positive results, indicating that this new bioassay is able to detect type A trichothecenes in the parts per billion range. In Europe, legal limits of T-2 and HT-2 for foods are in preparation but no definitive maximal residue levels have yet been issued. However, low limits of detection down to 10 ng/g, as achieved in the assays of Figure 7 , are considered to be necessary for accurate consumption surveys (Josephs et al., 2004) .
Conclusions
Existing bioassays for the detection of type A trichothecenes take advantage of cross-reactive antibodies that recognise both T-2 and HT-2 (Molinelli et al., 2008; Park and Chu, 1996; Schneider et al., 2004) . With the present report, we propose an alternative screening strategy based on the ability of type A trichothecenes to induce distinctive changes of transcription in easy-to-culture human epithelial cells. Transcriptomic methods require more trained personnel and substantially more time than current rapid tests for type A trichothecenes. However, a key advantage of this novel test is that it represents an effect-driven bioassay that exploits the regulation of biologically relevant genes (coding for cytokines as well as factors promoting cell death or DNA damage responses) in a toxicologically relevant target system (human epithelial cells). With the widespread use of rapid but indirect screening tests, which are not related to any toxicological endpoint, effect-based bioassays will become of increasing importance to facilitate risk assessment, support risk management decisions and monitor their true impact on food safety. Another advantage of this transcriptomic-based test is its ability to measure the additive biological activity of T-2 and HT-2. One of the aims of future work is to carry out intra-and inter-laboratory validation to determine whether the transcriptomic test may be suitable for enforcing future regulations involving a group residue limit that includes these two major type A trichothecenes. Our bioassay strategy also has the 
